Bausch Health Companies (BHC) Shares Outstanding (Diluted Average) (2009 - 2026)
Bausch Health Companies' (BHC) quarterly Shares Outstanding (Diluted Average) came in at $372.8 million in Q1 2026, up 0.87% year-on-year from $369.6 million in Q1 2025, and down 0.59% quarter-over-quarter from $375.0 million in Q4 2025.
Bausch Health Companies (BHC) Shares Outstanding (Diluted Average) (2009 - 2026) Analysis & Trends
Bausch Health Companies has disclosed Shares Outstanding (Diluted Average) across 16 years of filings, most recently posting $372.8 million for Q1 2026.
- Shares Outstanding (Diluted Average) for Q1 2026 came in at $372.8 million, up 0.87% year-over-year; the trailing twelve-month figure through Mar 2026 was $372.8 million (up 0.87% YoY), and the FY2025 annual result was $375.0 million, up 1.9% from the prior year.
- Shares Outstanding (Diluted Average) came in at $372.8 million for Q1 2026 at Bausch Health Companies, down from $375.0 million in the prior quarter.
- In the past five years, Shares Outstanding (Diluted Average) ranged from a high of $375.5 million in Q3 2025 to a low of $360.8 million in Q1 2022.
- The 5-year median for Shares Outstanding (Diluted Average) is $366.8 million (2024), against an average of $367.4 million.
- Across the five-year window, Shares Outstanding (Diluted Average) decreased 0.08% in 2022 and grew 2.12% in 2025, its largest moves.
- Bausch Health Companies' Shares Outstanding (Diluted Average) stood at $362.0 million in 2022, then climbed by 0.8% to $364.9 million in 2023, then grew by 0.85% to $368.0 million in 2024, then climbed by 1.9% to $375.0 million in 2025, then decreased by 0.59% to $372.8 million in 2026.
- The last three Shares Outstanding (Diluted Average) figures came in at $372.8 million (Q1 2026), $375.0 million (Q4 2025), and $375.5 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares (Diluted Avg.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 1.18 Bn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 422.40 Mn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 47.20 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 103.40 Mn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 506.00 Mn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | - |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | - |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | 228.36 Mn |
| 10 | Bausch Health Companies | 1.91 Bn | 1.58 Bn | 2.48 Bn | 372.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 372.80 Mn |
| Dec 31, 2025 | 375.00 Mn |
| Sep 30, 2025 | 375.50 Mn |
| Jun 30, 2025 | 373.10 Mn |
| Mar 31, 2025 | 369.60 Mn |
| Dec 31, 2024 | 368.00 Mn |
| Sep 30, 2024 | 367.70 Mn |
| Jun 30, 2024 | 370.20 Mn |
| Mar 31, 2024 | 366.80 Mn |
| Dec 31, 2023 | 364.90 Mn |
| Sep 30, 2023 | 365.40 Mn |
| Jun 30, 2023 | 364.10 Mn |
| Mar 31, 2023 | 363.30 Mn |
| Dec 31, 2022 | 362.00 Mn |
| Sep 30, 2022 | 363.70 Mn |
| Jun 30, 2022 | 362.20 Mn |
| Mar 31, 2022 | 360.80 Mn |
| Dec 31, 2021 | 358.90 Mn |
| Sep 30, 2021 | 364.00 Mn |
| Jun 30, 2021 | 358.00 Mn |